Pathogenesis and diagnosis of hereditary spherocytosis

Reading File

Finding Sources

Searching Images

hereditary spherocytosis peripheral blood smear spherocytes

Searching PubMed

hereditary spherocytosis diagnosis pathogenesis

From robbins book of pathology

Reading File

Finding Sources

Searching Images

hereditary spherocytosis peripheral blood smear spherocytes

A multi-panel clinical figure documenting phenotypic features of 8p11.2 deletion syndrome. Panel A shows clinical photographs (frontal and profile) of a patient exhibiting facial dysmorphism, including facial asymmetry, micrognathia (receding chin), and a malformed ear. Panel B displays a clinical photograph of a foot showing broad and foreshortened halluces. Panel C is a light microscopy image of a peripheral blood smear, where red arrows highlight small, hyperchromic spherocytes lacking central pallor, diagnostic of hereditary spherocytosis. Panel D is an axial non-contrast brain CT scan demonstrating symmetrical hyperdense areas consistent with intracranial calcifications in the bilateral lenticular nuclei, dorsal thalamus, and posterior horn of the lateral ventricles. This composite illustrates the contiguous gene syndrome involving FGFR1, ANK1, and SLC20A2 genes, which link combined hypogonadotropic hypogonadism, skeletal anomalies, spherocytosis, and primary familial brain calcification.

This diagnostic comparison chart utilizes Atomic Force Microscopy (AFM) to evaluate erythrocyte (red blood cell) morphology and surface ultrastructure in the context of Hereditary Spherocytosis (HS). The graphic compares three clinical states: Healthy Control, HS pre-splenectomy (pre-SE), and HS post-splenectomy (post-SE). Column A displays 10 m x 10 m topographic scans, highlighting the transition from a normal biconcave discocyte to a spherical, non-indented morphology in HS samples. Column B provides quantitative height profiles, showing the healthy cell's characteristic central dip (max height ~1 m) versus the increased vertical thickness (~2.25–2.4 m) of spherocytes. Column C presents 3D reconstructions further illustrating the loss of surface area-to-volume ratio in HS. Column D examines surface ultrastructure at a 1 m x 1 m scale, revealing changes in membrane granularity and roughness. This image serves as an educational tool for hematology and pathology, demonstrating the biophysical manifestations of membrane protein defects in hemolytic anemias and the stability of spherocytic morphology following splenectomy.

Peripheral blood smear from a patient with known chronic lymphocytic leukemia (CLL) showing autoimmune hemolytic anemia (AIHA). Brightfield microscopy of Wright-Giemsa stained smear at 1000x (oil immersion) reveals two dominant cell populations: numerous small mature lymphocytes typical of CLL and red blood cells showing spherocytic deformation. A smudge cell is evident just left of center, a classical clue for CLL. Red cells display reduced central pallor consistent with spherocytes, indicating intravascular or extravascular hemolysis driven by autoantibodies. The background shows mild polychromasia and rare nucleated RBCs, consistent with a robust reticulocyte response; the corrected reticulocyte count in this case is markedly elevated (>7%). Platelets are not significantly abnormal. These features collectively support autoimmune destruction of erythrocytes in the setting of CLL. Diagnostic significance lies in recognizing AIHA as a common autoimmune complication in CLL, with a clinical picture of sudden Hb decline and compensatory erythropoiesis. Differential considerations include drug-induced hemolysis, other causes of hemolytic anemia, or marrow infiltration by CLL. Clinical correlation includes therapy implications (steroids, rituximab) and close monitoring of hemolysis markers. This image is a valuable teaching resource for hematology morphology, AIHA in CLL, and differential diagnosis in anemia.

Reading File

Loading Image

Reading File

Loading Image

Reading File

I now have all the material needed from both Robbins textbooks, with full text on pathogenesis, morphology, clinical features, and diagnosis, plus the key diagrams and blood smear. Here is the complete answer:

Hereditary Spherocytosis - Pathogenesis & Diagnosis

Source: Robbins, Cotran & Kumar - Pathologic Basis of Disease + Robbins & Kumar Basic Pathology

Overview

Hereditary spherocytosis (HS) is an inherited disorder caused by intrinsic defects in the red cell membrane skeleton that render red cells spheroid, less deformable, and vulnerable to splenic sequestration and destruction. Its prevalence is highest in northern Europe (approximately 1 in 5000). About 75% of cases follow autosomal dominant inheritance; the remaining cases are more severe and usually result from compound heterozygosity (inheritance of two different defects).

Pathogenesis

Normal Red Cell Membrane Skeleton

The remarkable deformability and durability of the normal red cell depend on its specialized membrane skeleton, which lies closely apposed to the internal surface of the plasma membrane. Its major components are:

Spectrin - the chief protein, consisting of α and β polypeptide chains forming intertwined helical heterodimers. The "head" regions self-associate into tetramers; the "tails" associate with actin oligomers, creating a two-dimensional spectrin-actin meshwork.
Two tethering interactions connect this meshwork to the plasma membrane:
1. Ankyrin + band 4.2 - links spectrin to the transmembrane ion transporter band 3
2. Protein 4.1 - links the "tail" of spectrin to the transmembrane protein glycophorin A (GP)

Fig. 14.2 - Pathogenesis of Hereditary Spherocytosis (Robbins Pathologic Basis of Disease)

The upper panel shows the normal organization of major red cell membrane skeletal proteins. Mutations in α-spectrin, β-spectrin, ankyrin, band 4.2, or band 3 weaken the interactions between these proteins, destabilizing the red cell membrane and causing membrane fragment loss. - Robbins Pathologic Basis of Disease, p.597

Molecular Defects in HS

HS is caused by diverse mutations (usually frameshifts or premature stop codons) that lead to insufficiency of membrane skeletal proteins. The most commonly affected proteins are:

Protein Affected	Notes
Ankyrin	Most frequent mutation site
Band 3	Second most common
Spectrin (α or β)	Autosomal recessive forms tend to involve α-spectrin
Band 4.2	Less common

Most mutations cause the mutated allele to produce no protein at all, reducing overall assembly of the membrane skeleton.

Sequence of Events Leading to Spherocytosis

Membrane skeleton destabilization - loss or dysfunction of a skeletal protein weakens the anchoring of the lipid bilayer
Membrane vesicle shedding - the destabilized lipid bilayer progressively sheds membrane fragments as red cells age in circulation. Little cytoplasm is lost in the process.
Decreased surface area-to-volume ratio - loss of membrane "forces" the cell to assume the smallest possible diameter for a given volume - a sphere
Reduced deformability - the rigid spheroidal shape cannot undergo the extreme deformation required to traverse the narrow splenic sinusoids

Role of the Spleen

The spleen is the "villain" in HS. Normal biconcave red cells easily deform to squeeze from the splenic cords into the sinusoids. Spherocytes, due to their rigid shape, become trapped in the splenic cords - the phenomenon of erythrostasis. Within the cords:

Red cells are deprived of glucose
pH falls
K⁺ and H₂O are further lost, worsening dehydration
Resident macrophages phagocytose the trapped cells → extravascular hemolysis

The proof of the spleen's critical role is the invariably beneficial effect of splenectomy: although the red cell defect and spherocytes persist, the anemia is corrected after splenectomy.

Compound heterozygosity (two defective alleles) results in more profound membrane skeleton deficiency and more severe disease.

Morphology

Fig. 14.3 - HS peripheral blood smear (Robbins Pathologic Basis of Disease)

Note the variation in cell size (anisocytosis) and several dark spherocytes without central pallor. Howell-Jolly bodies (small, black nuclear remnants) are also seen in some red cells of this asplenic patient. - Robbins Pathologic Basis of Disease, p.597

Key morphological findings include:

Spherocytes on peripheral smear: small, dark-staining (hyperchromic) red cells lacking the zone of central pallor
Anisocytosis (variation in cell size)
Reticulocytosis (compensatory increased red cell production)
Erythroid hyperplasia in the bone marrow
Splenomegaly (500-1000 g; normal 150-200 g) - more prominent in HS than in most other hemolytic anemias. Caused by congestion of splenic cords and increased numbers of macrophages.
Cholelithiasis (pigment gallstones) in 40-50% of affected adults
Mild jaundice and hemosiderosis

Spherocytes are distinctive but not pathognomonic - they also appear in autoimmune hemolytic anemia and other conditions associated with red cell membrane loss.

Diagnosis

The diagnosis is based on family history, hematologic findings, and laboratory evidence.

Clinical Triad

Anemia (variable severity - from subclinical to profound; most commonly moderate)
Splenomegaly
Jaundice

Key Laboratory Findings

Finding	Significance
Spherocytes on peripheral smear (hyperchromic, no central pallor)	Hallmark morphological finding
Reticulocytosis	Compensatory erythropoiesis
Negative direct Coombs test	Distinguishes HS from autoimmune hemolytic anemia (which also has spherocytes)
Elevated MCHC (mean cell hemoglobin concentration)	Due to dehydration of HS red cells from loss of K⁺ and H₂O
Increased osmotic fragility	Spherocytes lyse more easily in hypotonic saline solutions compared with normal biconcave RBCs
Eosin-5'-maleimide (EMA) binding test	Fluorescent dye binds selectively to band 3; staining is decreased in HS due to membrane loss - a useful confirmatory test

Diagnostic Criteria Summary

The combination of:

Spherocytosis on smear
Reticulocytosis
Negative direct Coombs test

...is highly suggestive of HS. Elevated MCHC and reduced EMA binding confirm the diagnosis.

Clinical Course & Complications

Course is generally stable but punctuated by crises:
- Aplastic crises (most severe) - triggered by parvovirus B19 infection, which infects and kills erythroid progenitors. Since HS red cells have a shortened lifespan (10-20 days vs. normal 120 days), even 10-14 days without red cell production causes rapid, severe anemia. Transfusions may be required.
- Hemolytic crises - caused by events increasing splenic destruction (e.g., infectious mononucleosis with splenomegaly); clinically less significant than aplastic crises.
- Gallstone-related symptoms in patients with cholelithiasis.

Treatment

Splenectomy corrects the anemia by removing the major site of destruction. Spherocytes persist but are no longer rapidly destroyed.
Risk: Increased susceptibility to infections by encapsulated bacteria (especially in children).
Partial splenectomy is gaining favor in young children - provides hematologic benefit while preserving immune protection, though the spleen eventually regrows and a second resection may be needed later in childhood.

Robbins, Cotran & Kumar - Pathologic Basis of Disease, pp. 596-598; Robbins & Kumar Basic Pathology, pp. 384-385

Properly explain the pathology using flowcharts and the diagnosis and well

Generating Image

A clean, detailed medical pathogenesis flowchart for Hereditary Spherocytosis on a white background. The flowchart flows top to bottom with labeled boxes and arrows. Include these steps in order: TOP BOX (blue): "GENETIC MUTATIONS (Autosomal Dominant ~75% | Compound Heterozygous ~25%)" Arrow down to: BOX (orange): "Proteins affected: Ankyrin (most common) → Band 3 → β-Spectrin → α-Spectrin → Band 4.2" Arrow down labeled "Frameshift / Premature stop codon → No protein produced": BOX (red): "MEMBRANE SKELETON DEFICIENCY — Weakened anchoring of lipid bilayer to cytoskeleton" Arrow down labeled "As RBCs age in circulation": BOX (pink): "Lipid bilayer sheds membrane vesicles — Surface area lost WITHOUT loss of cytoplasm" Arrow down: BOX (yellow): "↓ Surface area : Volume ratio → Cell cannot maintain biconcave disc shape" Arrow down: BOX (orange-red): "SPHEROCYTE FORMATION — Small, round, hyperchromic RBC — No central pallor — ↓ Deformability" Arrow down labeled "Enters spleen": BOX (purple): "SPLENIC TRAPPING (Erythrostasis) — Spherocytes cannot deform to squeeze through splenic cord sinusoids — ↓ Glucose, ↓ pH — Further loss of K⁺ and H₂O" Two arrows from this box: Left arrow to BOX (dark red): "EXTRAVASCULAR HEMOLYSIS — Phagocytosis by splenic macrophages — RBC lifespan: 10–20 days (normal 120 days)" Right arrow back up to membrane loss box labeled "Worsens membrane loss" Arrow from hemolysis box down: BOX (green): "CONSEQUENCES: Anemia → Compensatory reticulocytosis + Erythroid hyperplasia → Splenomegaly → Jaundice (↑ unconjugated bilirubin) → Pigment gallstones (40–50%)" Use a clear sans-serif font, colored boxes with rounded corners, neat arrows with labels, professional medical education style.

Generating Image

A clean, detailed medical diagnostic flowchart for Hereditary Spherocytosis on a white background. Two-part flowchart: Part 1 "CLINICAL PRESENTATION" and Part 2 "LABORATORY DIAGNOSIS". Part 1 - Clinical Presentation (top section): Start box (blue): "PATIENT PRESENTATION" Three branches below it: Branch 1 box: "ANEMIA — Pallor, fatigue, variable severity (subclinical to severe)" Branch 2 box: "SPLENOMEGALY — 500–1000g (normal 150–200g) — Most prominent of all hemolytic anemias" Branch 3 box: "JAUNDICE — Unconjugated hyperbilirubinemia" All three merge to box: "FAMILY HISTORY — Autosomal dominant pattern — Affected parent/sibling" Part 2 - Laboratory Diagnosis (lower section): Box (yellow): "PERIPHERAL BLOOD SMEAR — Spherocytes: small, hyperchromic, no central pallor — Anisocytosis — Reticulocytosis — Howell-Jolly bodies (post-splenectomy)" Arrow to box (orange): "COMPLETE BLOOD COUNT — ↓ Hemoglobin — ↑ MCHC (elevated mean corpuscular hemoglobin concentration) — ↑ Reticulocyte count" Arrow to DECISION DIAMOND (red): "Direct Coombs Test" YES branch → box (red): "POSITIVE → Autoimmune Hemolytic Anemia (NOT HS) — Exclude HS" NO branch → box (green): "NEGATIVE → Supports HS diagnosis" Arrow from NO branch to box (blue): "CONFIRMATORY TESTS: 1. Osmotic Fragility Test — Spherocytes lyse in hypotonic saline — Increased fragility confirms HS 2. Eosin-5'-Maleimide (EMA) Binding Test — ↓ Fluorescence = ↓ Band 3 = HS 3. Acidified Glycerol Lysis Test (AGLT)" Arrow to final box (green): "CONFIRMED: HEREDITARY SPHEROCYTOSIS" Below that, box (red): "COMPLICATIONS TO MONITOR: • Aplastic crisis (Parvovirus B19) — most severe • Hemolytic crisis (e.g., EBV/mono) • Gallstones (pigment)" Box (purple): "TREATMENT: Splenectomy (corrects anemia, spherocytes persist)" Professional medical education style, sans-serif font, colored rounded boxes, clear arrows with labels.

Hereditary Spherocytosis - Complete Pathology & Diagnosis

Robbins, Cotran & Kumar - Pathologic Basis of Disease

PART 1 - PATHOGENESIS

Normal Red Cell Membrane - The Foundation

Before understanding what goes wrong in HS, you need to understand the normal membrane skeleton:

The red cell has a two-layer architecture:

Outer layer: Lipid bilayer (plasma membrane) containing transmembrane proteins (Band 3, Glycophorin)
Inner layer: Protein skeleton (spectrin, actin, ankyrin, band 4.1, band 4.2) that stabilizes the bilayer from below

The skeleton connects to the bilayer at two anchor points:

Spectrin → Ankyrin + Band 4.2 → Band 3 (main anchor)
Spectrin → Protein 4.1 → Glycophorin A (secondary anchor)

This gives the normal RBC its flexible biconcave disc shape, allowing extreme deformation without rupture.

Pathogenesis Flowchart

Step-by-Step Explanation of Each Stage

Step 1 - The Genetic Defect

Inheritance	Frequency	Notes
Autosomal Dominant	~75%	One defective allele; milder disease
Compound Heterozygous	~25%	Two different defective alleles; more severe

Mutations are mostly frameshifts or premature stop codons - the mutant allele produces no protein at all. The affected proteins in order of frequency:

Ankyrin - most common (links spectrin to Band 3)
Band 3 - second most common (the transmembrane anchor itself)
β-Spectrin - dominant mutations
α-Spectrin - recessive mutations (severe disease)
Band 4.2 - uncommon

Step 2 - Membrane Destabilization

With any one of these linker proteins deficient, the lipid bilayer loses its anchorage to the underlying cytoskeleton. The bilayer becomes unstable and prone to fragmentation.

Step 3 - Progressive Membrane Loss ("Vesiculation")

"The destabilized lipid bilayer sheds membrane fragments as the red cells age in the circulation." - Robbins PBD, p.597

Key point: Membrane (lipid bilayer) is shed but cytoplasm is retained
This progressively reduces the surface area without proportionally reducing cell volume

Step 4 - Spherocyte Formation

Because surface area decreases while volume stays constant:

The cell cannot maintain its biconcave disc shape
It adopts the minimum surface area geometry for a given volume = a sphere
This is purely a geometric/physical consequence - not a primary deformity

The spherocyte is:

Smaller in diameter
Hyperchromic (dark-staining) - more hemoglobin per unit volume
Lacks central pallor on smear
Rigid and non-deformable

Step 5 - Splenic Trapping (Erythrostasis)

This is where the spherocyte meets its end. The spleen is structured so that red cells must squeeze from the splenic cords through tiny slits (2-3 μm wide) into the sinusoids. Normal biconcave RBCs deform easily. Spherocytes cannot.

Trapped in the cords, the spherocyte faces a hostile microenvironment:

Glucose depletion (metabolic stress)
↓ pH (acidosis)
Further K⁺ and H₂O loss (more cell shrinkage and membrane damage)
The black feedback loop: more membrane is shed, worsening the spherocyte shape

This is erythrostasis - stasis of red cells in the splenic cords.

Step 6 - Extravascular Hemolysis

Macrophages lining the splenic cords phagocytose the trapped spherocytes. This is extravascular hemolysis (destruction outside blood vessels, within the spleen).

Normal RBC lifespan: 120 days
HS RBC lifespan: 10-20 days (up to 12x shorter)

Step 7 - Downstream Consequences

Consequence	Mechanism
Anemia	Accelerated RBC destruction outpaces production
Reticulocytosis	Bone marrow compensatory response
Erythroid hyperplasia	Marrow driven to overproduce RBCs
Splenomegaly (500-1000g)	Congested cords + ↑ macrophages
Jaundice	↑ Unconjugated bilirubin from heme breakdown
Pigment gallstones	↑ Bilirubin in bile, 40-50% of adults

Robbins Textbook Diagram

Fig. 14.2 - Pathogenesis of HS - Robbins PBD

Note the full cascade: membrane skeleton mutation → membrane loss → spherocyte → splenic trapping (erythrostasis, ↓ glucose, ↓ pH) → phagocytosis by splenic macrophage → extravascular hemolysis. - Robbins PBD, p.597

PART 2 - MORPHOLOGY

Peripheral Blood Smear

Small, dark (hyperchromic) spherocytes without central pallor, alongside normal-sized RBCs showing anisocytosis. Howell-Jolly bodies visible in asplenic patient. - Robbins PBD, p.597

What to look for on smear:

Feature	Appearance	Explanation
Spherocytes	Round, small, dark, no central pallor	Reduced surface:volume ratio
Anisocytosis	Variation in RBC size	Mix of spherocytes + normal cells + reticulocytes
Reticulocytes	Slightly larger, bluish (polychromasia)	Compensatory marrow output
Howell-Jolly bodies	Tiny dark nuclear remnants	Seen post-splenectomy (spleen normally removes these)

PART 3 - DIAGNOSIS

Diagnosis Flowchart

Hereditary Spherocytosis - Diagnostic Flowchart

Detailed Diagnostic Approach

Step 1 - Clinical Triad

Any patient presenting with all three of these should raise strong suspicion for HS:

Anemia (pallor, fatigue - variable from subclinical to severe)
Splenomegaly (often the most striking physical finding)
Jaundice (unconjugated, from hemolysis)

Plus a positive family history (autosomal dominant pattern - look for an affected parent or sibling).

Step 2 - Peripheral Blood Smear

The smear is the first and most important test:

Look for spherocytes - small, round, hyperchromic, no central pallor
Note anisocytosis and reticulocytosis
Spherocytes here = hemolytic anemia, but must differentiate HS from AIHA

Step 3 - Complete Blood Count (CBC)

CBC Parameter	Finding in HS	Why
Hemoglobin	↓	Hemolysis
MCV (mean cell volume)	Normal or slightly ↓	Spherocytes are small
MCHC	↑ (Elevated)	Dehydration of RBCs (K⁺ + H₂O loss) - concentrated hemoglobin
Reticulocytes	↑	Compensatory erythropoiesis
Bilirubin (unconjugated)	↑	Heme catabolism
LDH	↑	Hemolysis marker

Elevated MCHC is the single most important CBC clue to HS. It reflects the dehydrated, dense nature of spherocytes.

Step 4 - Direct Coombs Test (Direct Antiglobulin Test, DAT)

This is the critical fork in the road:

Spherocytes on smear
        |
        ▼
  Direct Coombs Test
   /            \
POSITIVE        NEGATIVE
   |               |
Autoimmune      Hereditary
Hemolytic       Spherocytosis
Anemia (AIHA)   (proceed to confirm)

HS is a membrane structural defect - no antibodies coat the RBCs. AIHA is an immune-mediated attack - antibodies or complement coat the RBCs.

The combination of spherocytosis + reticulocytosis + negative Coombs = highly suggestive of HS.

Step 5 - Confirmatory Tests

A. Osmotic Fragility Test (OFT)

Red cells are placed in tubes of decreasing NaCl concentration (hypotonic saline)
Normal biconcave RBCs can accommodate water entry (they have "extra" membrane)
Spherocytes already have minimal excess membrane → they burst (lyse) at higher salt concentrations than normal
HS result: Increased osmotic fragility (lysis begins earlier, at higher NaCl concentration)
Limitation: Can be normal in mild HS; also abnormal in AIHA

B. Eosin-5'-Maleimide (EMA) Binding Test (preferred modern test)

Fluorescent dye EMA binds specifically to Band 3 and Rh-associated glycoprotein
In HS, Band 3 protein is deficient or the membrane is reduced → decreased fluorescence
Measured by flow cytometry
HS result: ↓ EMA fluorescence (typically >20% reduction compared to normal)
More sensitive and specific than osmotic fragility; can detect milder cases

C. Acidified Glycerol Lysis Test (AGLT)

Alternative confirmatory test; less commonly used

D. Eosin-5'-maleimide (EMA) + Cryohemolysis (specialized centers)

Additional membrane studies

Step 6 - Molecular / Genetic Testing (when needed)

Gene sequencing for SPTA1 (α-spectrin), SPTB (β-spectrin), ANK1 (ankyrin), SLC4A1 (Band 3), EPB42 (Band 4.2)
Used for atypical cases, neonatal diagnosis, or genetic counseling
Not required for routine diagnosis

Summary Diagnostic Table

Test	Finding in HS	Purpose
Peripheral blood smear	Spherocytes, anisocytosis, reticulocytosis	First-line; morphological diagnosis
Hemoglobin	Decreased	Confirms anemia
MCHC	Elevated	Key CBC clue; dehydrated spherocytes
Reticulocyte count	Elevated	Compensatory erythropoiesis
Unconjugated bilirubin	Elevated	Hemolysis
Direct Coombs test	Negative	Excludes AIHA - key differentiator
Osmotic fragility	Increased	Confirmatory; spherocytes burst in hypotonic saline
EMA binding test	↓ Fluorescence	Best confirmatory test; detects Band 3 loss

PART 4 - COMPLICATIONS & CRISES

Crisis Type	Trigger	Mechanism	Severity
Aplastic crisis	Parvovirus B19	Kills erythroid progenitors → marrow stops RBC production for 10-14 days; with shortened RBC lifespan, Hb drops rapidly	Most severe
Hemolytic crisis	Infection (e.g., EBV/mono)	Splenomegaly increases splenic trapping	Moderate
Megaloblastic crisis	Folate deficiency	Increased RBC turnover depletes folate stores	Less common
Cholelithiasis	Chronic hyperbilirubinemia	Pigment gallstones in 40-50% adults	Symptomatic gallstone disease

KEY CONCEPT SUMMARY

Mutation in membrane skeleton protein
         ↓
Reduced surface area (membrane vesiculation)
         ↓
Spherocyte formation (geometry dictates sphere)
         ↓
Splenic trapping (cannot deform through sinusoidal slits)
         ↓
Erythrostasis → glucose↓, pH↓ → more membrane loss
         ↓
Macrophage phagocytosis → Extravascular hemolysis
         ↓
Anemia + Splenomegaly + Jaundice + Gallstones

Diagnosis confirmed by: Spherocytes on smear + Negative Coombs + Elevated MCHC + Increased osmotic fragility/↓ EMA binding

Treatment: Splenectomy removes the site of destruction - anemia corrected, spherocytes persist but survive longer.

Robbins, Cotran & Kumar - Pathologic Basis of Disease, pp. 596-598 | Robbins & Kumar Basic Pathology, pp. 384-385

What are the laboratory findings in iron deficiency anemia

Reading File

Finding Sources

Searching Images

iron deficiency anemia peripheral blood smear microcytic hypochromic

This composite image consists of clinical photographs and a diagnostic peripheral blood smear. Figure 1a (left) shows a pediatric patient with clinical signs including total alopecia (complete absence of scalp hair) and nail pitting affecting both hands and feet, characterized by small punctate depressions on the nail plates. Figure 1b (right) is a microscopic view of a peripheral blood smear demonstrating microangiopathic hemolytic anemia. Visible are numerous schistocytes—fragmented, irregular red blood cells including helmet cells and triangular forms—alongside some normal erythrocytes showing central pallor. The educational focus is on the multi-systemic manifestations of a medical condition, likely a microangiopathic process such as Hemolytic Uremic Syndrome (HUS) or similar systemic pathology, illustrating the correlation between dermatological signs (hair and nail changes) and hematological abnormalities (hemolysis and schistocytosis).

Peripheral blood smear prepared with Wright-Giemsa stain and examined under brightfield illumination using a 100× oil immersion objective reveals a single large plasma cell among a field of mature erythrocytes. The plasma cell displays features typical of clonal plasma cells: basophilic cytoplasm, an eccentrically placed round nucleus, and a conspicuous perinuclear hof; background shows rouleaux formation of red cells. This image exemplifies hematologic involvement by a plasma cell dyscrasia. In plasma cell leukemia, circulating plasma cells constitute more than 20% of leukocytes, a hallmark distinguishing it from conventional multiple myeloma, although both conditions share monoclonal plasma cell proliferation. The presence of circulating plasma cells is associated with younger patient age, higher incidence of anemia, thrombocytopenia, organomegaly, and possible lymphadenopathy; however lytic bone lesions may be less common. Immunophenotypic patterns often include lack of CD56 expression relative to myeloma. Clinically, this morphological finding warrants confirmation with complete blood count, peripheral smear review, quantitative plasma cell percentage, serum protein electrophoresis, and immunofixation to identify monoclonal immunoglobulin isotype (IgD/IgE or light-chain predominance). Early detection of circulating plasma cells supports prognosis assessment and guides therapy decisions in plasma cell dyscrasia management and monitoring, including risk stratification and treatment response evaluation for practice in clinics.

Reading File

Loading Image

Reading File

I now have everything I need from Robbins PBD for a comprehensive answer. Let me compose the full response.

Laboratory Findings in Iron Deficiency Anemia

Source: Robbins, Cotran & Kumar - Pathologic Basis of Disease + Robbins & Kumar Basic Pathology

Understanding the Sequence: Stages of Iron Depletion

Iron deficiency does not appear all at once. It develops in three progressive stages, and the lab findings reflect whichever stage the patient is in:

Stage	What is depleted	Lab change
Stage 1 - Pre-latent (Storage depletion)	Iron stores (ferritin/hemosiderin)	↓ Serum ferritin, absent marrow iron
Stage 2 - Latent (Transport iron depletion)	Circulating transport iron	↓ Serum iron, ↑ TIBC, ↓ Transferrin saturation
Stage 3 - Frank IDA (Functional iron depletion)	Hemoglobin synthesis impaired	↓ Hb, ↓ MCV, ↓ MCH, microcytic hypochromic anemia on smear

Complete Blood Count (CBC) Findings

Parameter	Finding	Explanation
Hemoglobin (Hb)	Decreased	Insufficient iron for hemoglobin synthesis
Hematocrit (Hct)	Decreased	Proportional to low Hb
MCV (Mean Corpuscular Volume)	Decreased (<80 fL)	RBCs are smaller due to inadequate Hb fill - microcytosis
MCH (Mean Corpuscular Hemoglobin)	Decreased	Less hemoglobin per cell
MCHC (Mean Corpuscular Hb Concentration)	Decreased	Cells are pale/dilute in hemoglobin - hypochromia
RDW (Red Cell Distribution Width)	Increased	Anisocytosis - variable cell sizes as iron depletes progressively
Reticulocyte count	Low or normal	Unlike hemolytic anemia, marrow cannot produce adequately due to substrate deficiency; reticulocyte production index is low
Platelets	Often elevated (reactive thrombocytosis)	Especially in chronic blood loss as a cause
WBC	Usually normal

Iron Studies (The Diagnostic Core)

Test	Normal Value	Finding in IDA	Explanation
Serum Ferritin	12-150 μg/L (women); 15-200 μg/L (men)	↓↓ (<12 μg/L)	Most sensitive early marker; reflects storage pool depletion
Serum Iron	~100-120 μg/dL	↓ Decreased	Less iron in circulation
TIBC (Total Iron Binding Capacity)	300-350 μg/dL	↑ Increased	Reflects elevated transferrin - body upregulates transferrin to "capture" any available iron
Transferrin Saturation	~33%	↓ <15%	Low serum iron ÷ high TIBC = very low saturation
Serum Hepcidin	Normal varies	↓ Decreased	Low iron stores inhibit hepcidin synthesis; hepcidin falls to maximize iron absorption
Serum Transferrin Receptor (sTfR)	<28 nmol/L	↑ Increased	Erythroid precursors upregulate TfR when iron-starved; reflects tissue iron deficiency even when ferritin is falsely normal (inflammation)

Key diagnostic formula: Low serum ferritin + Low transferrin saturation (<15%) + Elevated TIBC = Iron Deficiency Anemia

Peripheral Blood Smear Findings

Fig. 14.22 - IDA Peripheral Blood Smear - Robbins PBD

Hypochromic microcytic red cells with a narrow peripheral rim of hemoglobin. Some fully hemoglobinized cells seen due to recent transfusion. A single neutrophil is visible bottom-right. - Robbins PBD, p.615

What to see on smear:

Finding	Description
Microcytosis	RBCs smaller than normal lymphocyte nucleus
Hypochromia	Enlarged zone of central pallor (>1/3 cell diameter); hemoglobin confined to a narrow rim at the periphery
Anisocytosis	Variation in cell size (elevated RDW reflects this)
Poikilocytosis	Abnormal shapes
"Pencil cells" (Elliptocytes)	Small, elongated, cigar-shaped red cells - characteristic of IDA
Target cells	Occasionally seen

Bone Marrow Findings

Mild to moderate erythroid hyperplasia - marrow working harder to produce RBCs
Absent stainable iron in macrophages - the most diagnostically significant marrow finding
- Best assessed by Prussian blue stain on aspirated marrow smears
- In iron overload, macrophages are packed with blue-staining hemosiderin; in IDA, they are completely empty
Erythroid precursors appear small with scanty cytoplasm

Bone marrow iron assessment is the gold standard for diagnosing IDA but is invasive, so serum studies are done first.

Summary Table: IDA Lab Profile at a Glance

Lab Test	IDA	Anemia of Chronic Disease	Thalassemia Trait
Hemoglobin	↓	↓	↓ (mild)
MCV	↓ (microcytic)	↓ or normal	↓ (microcytic)
Serum Ferritin	↓↓	↑ or normal	Normal
Serum Iron	↓	↓	Normal
TIBC	↑	↓ or normal	Normal
Transferrin Sat.	↓ (<15%)	↓	Normal
Serum Hepcidin	↓	↑ (key difference)	Normal
sTfR	↑	Normal/↑	Normal
Marrow iron	Absent	Increased	Normal
RDW	↑ (high)	Normal or ↑	Normal (low RDW helps differentiate from IDA)

Response to Treatment (An Additional Diagnostic Test)

In uncomplicated IDA, oral iron supplementation produces:

Reticulocytosis within 5-7 days (first sign of response - the marrow surges)
Followed by a steady rise in hemoglobin
Normalization of red cell indices over weeks

Failure to respond to oral iron should prompt investigation of: malabsorption (celiac disease), ongoing blood loss, non-compliance, or wrong diagnosis.

Key Clinical Clues Pointing to the Cause

The lab findings confirm IDA, but the underlying cause must be identified:

Premenopausal women / pregnancy - blood loss / increased demand
Men or postmenopausal women - gastrointestinal blood loss until proven otherwise (occult blood in stool, endoscopy)
Infants/toddlers - inadequate dietary iron
Malabsorption (celiac, gastric bypass) - impaired duodenal absorption

Robbins, Cotran & Kumar - Pathologic Basis of Disease, pp. 612-615 | Robbins & Kumar Basic Pathology, pp. 393-396

This is a shared conversation. Sign in to Orris to start your own chat.